The orthopedic joint replacement market growth in 2026 is evolving rapidly as healthcare providers increasingly adopt advanced implants, robotic-assisted procedures, patient-specific solutions, and innovative surgical technologies. Orthopedic joint replacement procedures are widely used for treating joint-related conditions, particularly osteoarthritis, and have gained broader acceptance among patients seeking improved mobility and treatment options. The rising geriatric population, increasing incidence of hip fractures, and growing number of knee and hip replacement procedures are contributing to market expansion.
According to Fortune Business Insights, the global orthopedic joint replacement market size was estimated at USD 25.94 billion in 2025. The market is expected to rise from USD 27.99 billion in 2026 to USD 51.42 billion by 2034, expanding at a CAGR of 7.90% from 2026 to 2034. North America dominated the orthopedic joint replacement market with a market share of 36.13% in 2025. The knee segment is projected to lead the market with a 43.0% share in 2026.
Orthopedic joint replacement involves surgical procedures in which damaged or diseased joint surfaces are replaced with artificial implants. Knee, hip, shoulder, and ankle replacements represent important product categories within the market. The increasing prevalence of osteoarthritis among the geriatric population has strengthened the demand for joint replacement procedures. Fortune Business Insights highlights that joint replacement has emerged as a popular treatment option for osteoarthritis, while the rising elderly population is also contributing to the incidence of hip fractures. Technological developments are changing the orthopedic joint replacement landscape. Robotic surgery, artificial intelligence-based tools, three-dimensional printing, and customized implants are supporting the development of more patient-specific approaches. Manufacturers are focusing on technologies that address differences in patient anatomy and provide advanced options for orthopedic procedures.
Technological innovation is an important factor supporting the growth of the orthopedic joint replacement market. The increasing demand for customized implants for male and female patients has encouraged medical device companies to develop patient-specific solutions. Fortune Business Insights notes that the concept of a one-size-fits-all implant is not applicable to every patient because of anatomical differences. The adoption of 3D printing has also supported the development of customized orthopedic implants.
The increasing use of surgical robots in orthopedics is another important growth factor. Robotic technologies can support orthopedic teams during joint replacement procedures, while manufacturers are developing robotic systems for total and partial knee arthroplasties. The introduction of advanced robotic platforms and navigation technologies is expected to support the adoption of joint replacement devices.
Osteoarthritis is prevalent among older adults and is an important factor behind the demand for joint replacement procedures. The growing geriatric population and increasing incidence of hip fractures are creating additional demand for orthopedic implants. The expanding number of knee replacement procedures is also supporting the market.
Product recalls and complications associated with orthopedic implants may restrain market growth. Fortune Business Insights reports that the U.S. Food and Drug Administration recorded more than 13,000 recalls of knee replacement components and systems between 2003 and 2019. Such recalls and lawsuits related to orthopedic devices can affect market expansion and patient confidence.
The competitive landscape is characterized by the presence of prominent orthopedic device companies offering diversified joint implant portfolios. Zimmer Biomet, Stryker, Johnson & Johnson Services, Inc., and Smith + Nephew are identified by Fortune Business Insights as prominent players. These companies focus on diversified joint implant offerings for upper and lower extremities and are involved in product launches and technology development.
Recent industry activity includes Stryker's advancements in Mako SmartRobotics™, Smith + Nephew's orthopedic technologies and CORI Surgical System, Zimmer Biomet's focus on total knee and total hip arthroplasty education, and Enovis' introduction of foot and ankle surgery offerings. The competitive environment is also supported by product development and expanding technology portfolios.
Stryker (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
Smith + Nephew (U.K.)